Clovis Oncology, Inc.·4

Aug 16, 6:10 PM ET

McKinley Edward J 4

4 · Clovis Oncology, Inc. · Filed Aug 16, 2012

Insider Transaction Report

Form 4
Period: 2012-08-14
Transactions
  • Purchase

    Common Stock

    2012-08-16$15.66/sh+3,500$54,810295,431 total
  • Purchase

    Common Stock

    2012-08-14$15.40/sh+5,201$80,095290,931 total
  • Purchase

    Common Stock

    2012-08-15$15.50/sh+1,000$15,500291,931 total
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.32 to $15.50, inclusive. The reporting person undertakes to provide to Clovis Oncology, Inc., any security holder of Clovis Oncology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.48 to $15.50, inclusive.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.42 to $15.87, inclusive.

Documents

1 file
  • 4
    rrd353515.xmlPrimary

    FORM 4